Increased expression of cell-cell signaling genes by stimulated mononuclear leukocytes in patients with previous atherothrombotic stroke: A whole genome expression profile study

European Neurology

Volumn 62, Issue 1, 2009, Pages 30-39

  Grond Ginsbach, Caspar ^a   Horstmann, Solveig ^a   Hummel, Manuela ^b   Wiest, Tina ^a   Honold, Cornelius ^a   Pfleger, Karin ^a   Hergenhahn, Manfred ^c   Hollstein, Monika ^c   Weninger, Annette ^c   Knyazev, Yuri ^c   Mansmann, Ulrich ^b   Wagner, Simone ^a   Grau, Armin J ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Blood; Endotoxin, bacterial; Gene expression; Mononuclear cells; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPOLYSACCHARIDE; RNA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROTHROMBOTIC STROKE; CELL CELL SIGNALING GENE; CELL INTERACTION; CELL STIMULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC DIFFERENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; STROKE; STROKE PATIENT;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; GENE EXPRESSION; GENOME; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROKE;

EID: 65449132103     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215878     Document Type: Article

References (34)

1. Libby P, Ridker PM, Maseri A: Inf lammation and atherosclerosis. Circulation 2002;105:1135-1143.
2. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
3. Grau AJ, Aulmann M, Lichy C, Meiser H, Buggle F, Brandt T, Grond-Ginsbach C: Increased cytokine release by leucocytes in survivors of stroke at young age. Eur J Clin Invest 2001;31:999-1006.
4. Elkind MS: Inflammation, atherosclerosis, and stroke. Neurologist 2006;12:140-148.
5. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farri ng ton P, Valla nce P: R isk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-2618.
6. Lindsberg PJ, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 2003;34:2518-2532.
7. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R: Proinf lammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004;35:2270-2275.
8. Markus HS, Labrum R, Bevan S, Reindl M, Egger G, Wiedermann CJ, Xu O, Kiechl S, Willeit J: Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 2006;37:2253-2259.
9. Grond-Ginsbach C, Hummel M, Wiest T, Horstmann S, Pfleger K, Hergenhahn M, Hollstein M, Mansmann U, Grau AJ, Wagner S: Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol 2008;255:723-731.
10. Moore DF, Li H, Jeffries N, Wright V, Cooper RA, Elkahloun A, Gelderman MP, Zudaire E, Blevins G, Yu H, Goldin E, Baird AE: Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 2005;111:212-221.
11. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, Ran R, Gregg JP, Reilly M, Pancioli A, Khoury JC, Sauerbeck LR, Carrozzella JA, Spilker J, Clark J, Wagner KR, Jauch EC, Chang DJ, Verro P, Broderick JP, Sharp FR: Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 2006;26:1089-1102.
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformat-ics. Genome Biol 2004;5:R80.
13. Wu Z, Irizarry RA, Gentleman R, Martinez Murillo F, Spencer F: A model-based background adjustment for oligonucleotide expression arrays. J Am Statist Assoc 2004;99:909-917.
14. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
15. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez MV, Kitrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME: A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003;114:323-334.
16. Mansmann U, Meister R: Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods Inf Med 2005;44:449-453.
17. Yue L, Reisdorf WC: Pathway and ontology analysis: emerging approaches connecting transcriptome data and clinical endpoints. Curr Mol Med 2005;5:11-21.
18. Stolovitzky GA, Kundaje A, Held GA, Dug-gar KH, Haudenschild CD, Zhou D, Vasicek TJ, Smith KD, Aderem A, Roach JC: Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression. Proc Nat Acad Sci USA 2005;102:1402-1407.
19. Brenner D, Labreuche J, Touboul PJ, Schmidt-Petersen K, Poirier O, Perret C, Schönfelder J, Combadière C, Lathrop M, Cambien F, Brand-Herrmann SM, Amarenco P: Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke 2006;37:1691-1696.
20. Worrall BB, Brott TG, Brown RD, Brown WM, Rich SS, Arepalli S, Wavrant-De Vrièze F, Duckworth J, Singleton AB, Hardy J, Meschia JF: IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations. Stroke 2007;38:1189-1196.
21. McCabe DJH, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Martin M, Machin SJ: Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004;125:777-787.
22. Härtel C, von Puttkamer J, Gallner F, Strunk T, Schultz C: Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scand J Immunol 2004;60:412-420.
23. Storey RF, Judge HM, Wilcox RG, Heptinstall S: Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost 2002;88:488-494.
24. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W: Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004;35:1147-1152.
25. Matarin M, Brown WM, Scholz S, Simon-Sanchez J, Fung HC, Hernandez D, Gibbs JR, De Vrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD, Worral BB, Frankel M, Sillimar S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF: A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 2007;6:414-420.
26. Gant TW: Inflammatory genomics. Environ Health Perspect 2005;113:A794-A795.
27. Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T: Relationships of plasma interleukin-18 concentrations to hyperho-mocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care 2003;26:2622-2627.
28. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-1603.
29. Anderson JL, Carlquist JF: Cytokines, inter-leukin-18, and the genetic determinants of vascular inflammation. Circulation 2005;112:620-623.
30. Yatsiv I, Morganti-Kossmann MC, Perez D, Dinarello CA, Novick D, Rubinstein M, Otto VI, Rancan M, Kossmann T, Redaelli CA, Trentz O, Shohami E, Stahel PF: Elevated in-tracranial IL-18 in humans and mice after traumatic brain injury and evidence of neu-roprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab 2002;22:971-978.
31. Mohan K, Ding Z, Hanly J, Issekutz TB: IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha. J Immunol 2002;16 8:6420-6428.
32. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM: Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001;167:623-627.
33. Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN, Sommer C, Schwab S: Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-751.
34. Schneider A, Kuhn HG, Schäbitz WR: A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 2005;4:1753-1757.